Mounting evidence suggests that in addition to thermal ablation of cancer cells, HIFU may also boost the host antitumor immune response including CD4+/CD8+ related tumor-infiltrating lymphocytes (TILs) [16,17], dendritic cells (DCs) [18], and antigen presenting cells (APCs)[19]. The gene discussed is CD4; the disease is neoplasm.